• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性鸟苷酸环化酶刺激剂和激活剂:我们在哪里,我们要去哪里?

Soluble Guanylate Cyclase Stimulators and Activators: Where are We and Where to Go?

机构信息

Department of Medicinal Chemistry, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, Hunan, China.

Department of Chemistry, Graduate School of Science Kyoto University Kitashirakawa- Oiwakecho, Sakyo-Ku, kyoto, Japan.

出版信息

Mini Rev Med Chem. 2019;19(18):1544-1557. doi: 10.2174/1389557519666190730110600.

DOI:10.2174/1389557519666190730110600
PMID:31362687
Abstract

Soluble Guanylate Cyclase (sGC) is the intracellular receptor of Nitric Oxide (NO). The activation of sGC results in the conversion of Guanosine Triphosphate (GTP) to the secondary messenger cyclic Guanosine Monophosphate (cGMP). cGMP modulates a series of downstream cascades through activating a variety of effectors, such as Phosphodiesterase (PDE), Protein Kinase G (PKG) and Cyclic Nucleotide-Gated Ion Channels (CNG). NO-sGC-cGMP pathway plays significant roles in various physiological processes, including platelet aggregation, smooth muscle relaxation and neurotransmitter delivery. With the approval of an sGC stimulator Riociguat for the treatment of Pulmonary Arterial Hypertension (PAH), the enthusiasm in the discovery of sGC modulators continues for broad clinical applications. Notably, through activating the NO-sGC-cGMP pathway, sGC stimulator and activator potentiate for the treatment of various diseases, such as PAH, Heart Failure (HF), Diabetic Nephropathy (DN), Systemic Sclerosis (SS), fibrosis as well as other diseases including Sickle Cell Disease (SCD) and Central Nervous System (CNS) disease. Here, we review the preclinical and clinical studies of sGC stimulator and activator in recent years and prospect for the development of sGC modulators in the near future.

摘要

可溶性鸟苷酸环化酶(sGC)是一氧化氮(NO)的细胞内受体。sGC 的激活导致鸟苷三磷酸(GTP)转化为第二信使环鸟苷酸(cGMP)。cGMP 通过激活各种效应物,如磷酸二酯酶(PDE)、蛋白激酶 G(PKG)和环核苷酸门控离子通道(CNG),调节一系列下游级联反应。NO-sGC-cGMP 途径在各种生理过程中发挥重要作用,包括血小板聚集、平滑肌松弛和神经递质传递。随着 sGC 刺激剂 Riociguat 被批准用于肺动脉高压(PAH)的治疗,人们对 sGC 调节剂的发现热情持续高涨,以期广泛应用于临床。值得注意的是,通过激活 NO-sGC-cGMP 途径,sGC 刺激剂和激活剂增强了治疗各种疾病的作用,如 PAH、心力衰竭(HF)、糖尿病肾病(DN)、系统性硬化症(SS)、纤维化以及其他疾病,包括镰状细胞病(SCD)和中枢神经系统(CNS)疾病。在这里,我们回顾了近年来 sGC 刺激剂和激活剂的临床前和临床研究,并对 sGC 调节剂的近期发展进行了展望。

相似文献

1
Soluble Guanylate Cyclase Stimulators and Activators: Where are We and Where to Go?可溶性鸟苷酸环化酶刺激剂和激活剂:我们在哪里,我们要去哪里?
Mini Rev Med Chem. 2019;19(18):1544-1557. doi: 10.2174/1389557519666190730110600.
2
Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure.一氧化氮-可溶性鸟苷酸环化酶-环磷酸鸟苷信号通路的治疗性增强:从肺动脉高压和心力衰竭中汲取的经验教训。
Heart Fail Rev. 2022 Nov;27(6):1991-2003. doi: 10.1007/s10741-022-10239-5. Epub 2022 Apr 18.
3
The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase.肺动脉高压中的一氧化氮-可溶性鸟苷酸环化酶-cGMP 途径:从 PDE5 到可溶性鸟苷酸环化酶。
Eur Respir Rev. 2024 Mar 20;33(171). doi: 10.1183/16000617.0183-2023. Print 2024 Jan 31.
4
Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.在心血管疾病中使用BAY 41-2272对可溶性鸟苷酸环化酶进行不依赖一氧化氮的刺激。
Cardiovasc Drug Rev. 2007 Spring;25(1):30-45. doi: 10.1111/j.1527-3466.2007.00003.x.
5
Exploring the potential of NO-independent stimulators and activators of soluble guanylate cyclase for the medical treatment of erectile dysfunction.探索非一氧化氮依赖的可溶性鸟苷酸环化酶刺激剂和激活剂在治疗勃起功能障碍中的医学应用潜力。
Curr Pharm Des. 2010 May;16(14):1619-33. doi: 10.2174/138161210791164162.
6
Soluble Guanylate Cyclase Stimulators and Activators.可溶性鸟苷酸环化酶刺激剂和激活剂。
Handb Exp Pharmacol. 2021;264:355-394. doi: 10.1007/164_2018_197.
7
Soluble guanylate cyclase stimulators in pulmonary hypertension.肺动脉高压中的可溶性鸟苷酸环化酶刺激剂。
Handb Exp Pharmacol. 2013;218:279-313. doi: 10.1007/978-3-642-38664-0_12.
8
Anti-fibrotic effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidence.可溶性鸟苷酸环化酶刺激剂和激活剂的抗纤维化作用:临床前证据综述
Respir Med. 2017 Jan;122 Suppl 1:S1-S9. doi: 10.1016/j.rmed.2016.08.022. Epub 2016 Aug 25.
9
Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.可溶性鸟苷酸环化酶:肺动脉高压和慢性血栓栓塞性肺动脉高压的新治疗靶点。
Clin Pharmacol Ther. 2015 Jan;97(1):88-102. doi: 10.1002/cpt.10. Epub 2014 Nov 28.
10
Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure.用于治疗心力衰竭的新型可溶性鸟苷酸环化酶刺激剂和可溶性鸟苷酸环化酶激活剂
Handb Exp Pharmacol. 2017;243:225-247. doi: 10.1007/164_2016_100.

引用本文的文献

1
Analysis of research trends and development prospects of soluble guanylate cyclase stimulators/activators: using bibliometric methods.可溶性鸟苷酸环化酶刺激剂/激活剂的研究趋势与发展前景分析:运用文献计量学方法
Front Pharmacol. 2025 Jun 10;16:1501330. doi: 10.3389/fphar.2025.1501330. eCollection 2025.
2
Peripheral Antinociception Induced by Carvacrol in the Formalin Test Involves the Opioid Receptor-NO-cGMP-K Channel Pathway.香芹酚在福尔马林试验中诱导的外周抗伤害感受涉及阿片受体-NO-cGMP-K通道途径。
Metabolites. 2025 May 7;15(5):314. doi: 10.3390/metabo15050314.
3
(-)-Carvone Inhibits Oxytocin-induced Writhing Via Uterine Relaxation in Rodents.
(-)-香芹酮通过子宫松弛抑制催产素诱导的扭体反应在啮齿动物中。
Reprod Sci. 2024 Oct;31(10):3039-3048. doi: 10.1007/s43032-024-01663-z. Epub 2024 Aug 1.
4
Examining the contribution of Notch signaling to lung disease development.探讨 Notch 信号通路在肺部疾病发展中的作用。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):6337-6349. doi: 10.1007/s00210-024-03105-8. Epub 2024 Apr 23.
5
Vericiguat in patients with heart failure across the spectrum of left ventricular ejection fraction: a patient-level, pooled meta-analysis of VITALITY-HFpEF and VICTORIA.维立西呱在射血分数保留型心力衰竭患者中的应用:VITALITY-HFpEF 和 VICTORIA 的患者水平 pooled 荟萃分析。
Front Endocrinol (Lausanne). 2024 Mar 8;15:1335531. doi: 10.3389/fendo.2024.1335531. eCollection 2024.
6
Pharmacological Stimulation of Soluble Guanylate Cyclase Counteracts the Profibrotic Activation of Human Conjunctival Fibroblasts.药理学刺激可溶性鸟苷酸环化酶可拮抗人结膜成纤维细胞的促纤维化激活。
Cells. 2024 Feb 18;13(4):360. doi: 10.3390/cells13040360.
7
Heart failure with preserved ejection fraction and non-alcoholic fatty liver disease: new insights from bioinformatics.射血分数保留的心力衰竭与非酒精性脂肪性肝病:生物信息学的新见解。
ESC Heart Fail. 2023 Feb;10(1):416-431. doi: 10.1002/ehf2.14211. Epub 2022 Oct 20.
8
Carbon Monoxide Signaling: Examining Its Engagement with Various Molecular Targets in the Context of Binding Affinity, Concentration, and Biologic Response.一氧化碳信号转导:结合结合亲和力、浓度和生物学反应考察其与各种分子靶标的相互作用。
Pharmacol Rev. 2022 Jul;74(3):823-873. doi: 10.1124/pharmrev.121.000564.
9
Carbon monoxide signaling and soluble guanylyl cyclase: Facts, myths, and intriguing possibilities.一氧化碳信号转导与可溶性鸟苷酸环化酶:事实、迷思与饶富趣味的可能性。
Biochem Pharmacol. 2022 Jun;200:115041. doi: 10.1016/j.bcp.2022.115041. Epub 2022 Apr 18.
10
Management of Endothelial Dysfunction in Systemic Sclerosis: Current and Developing Strategies.系统性硬化症中内皮功能障碍的管理:当前及发展中的策略
Front Med (Lausanne). 2021 Dec 22;8:788250. doi: 10.3389/fmed.2021.788250. eCollection 2021.